Renal Effects of the Novel Selective Adenosine A1 Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats

Berthold Hocher; Susi Heiden; Karoline von Websky; Ayman M. Arafat; Jan Rahnenführer; Markus Alter; Philipp Kalk; Dieter Ziegler; Yvan Fischer; Thiemo Pfab

doi:10.1371/journal.pone.0017891

Loading metrics

Open Access

Peer-reviewed

Research Article

Renal Effects of the Novel Selective Adenosine A₁ Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats

Berthold Hocher ,

Contributed equally to this work with: Berthold Hocher, Susi Heiden

Affiliations Institute of Nutritional Science, University of Potsdam, Potsdam, Germany, Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany
⨯
Susi Heiden ,

Contributed equally to this work with: Berthold Hocher, Susi Heiden

Affiliation Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany
⨯
Karoline von Websky,

Affiliations Institute of Nutritional Science, University of Potsdam, Potsdam, Germany, Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany
⨯
Ayman M. Arafat,

Affiliations Department of Endocrinology, Diabetes and Nutrition, Charité Campus Benjamin Franklin, Berlin, Germany, Department of Clinical Nutrition, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany
⨯
Jan Rahnenführer,

Affiliations Institute of Nutritional Science, University of Potsdam, Potsdam, Germany, Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany
⨯
Markus Alter,

Affiliations Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany, Department of Nephrology, Charité Campus Benjamin Franklin, Berlin, Germany
⨯
Philipp Kalk,

Affiliations Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany, Department of Nephrology, Charité Campus Benjamin Franklin, Berlin, Germany
⨯
Dieter Ziegler,

Affiliation Abbott Products GmbH, Hannover, Germany
⨯
Yvan Fischer,

Affiliation Abbott Products GmbH, Hannover, Germany
⨯
Thiemo Pfab

* E-mail: berthold.hocher@charite.de

Affiliations Center for Cardiovascular Research/Institute of Pharmacology, Charité, Berlin, Germany, Department of Nephrology, Charité Campus Benjamin Franklin, Berlin, Germany
⨯

Renal Effects of the Novel Selective Adenosine A₁ Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats

Berthold Hocher,
Susi Heiden,
Karoline von Websky,
Ayman M. Arafat,
Jan Rahnenführer,
Markus Alter,
Philipp Kalk,
Dieter Ziegler,
Yvan Fischer,
Thiemo Pfab

Published: March 10, 2011
https://doi.org/10.1371/journal.pone.0017891

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cirrhosis
Is the Subject Area "Cirrhosis" applicable to this article?

Thanks for your feedback.
Adenosine
Is the Subject Area "Adenosine" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.
Kidneys
Is the Subject Area "Kidneys" applicable to this article?

Thanks for your feedback.
Excretion
Is the Subject Area "Excretion" applicable to this article?

Thanks for your feedback.
Diuretics
Is the Subject Area "Diuretics" applicable to this article?

Thanks for your feedback.
Urine
Is the Subject Area "Urine" applicable to this article?

Thanks for your feedback.
Receptor binding assays
Is the Subject Area "Receptor binding assays" applicable to this article?

Thanks for your feedback.